Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
- PMID: 27789718
- DOI: 10.2967/jnumed.116.179663
Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET
Abstract
68Ga-pentixafor is a radiotracer for PET that binds with nanomolar affinity to CXCR4. The CXCR4 receptor is expressed at the surface of inflammatory cells. The objective of the study was to analyze the ability of radiolabeled pentixafor to detect CXCR4 expression on inflammatory cells present in atherosclerotic plaques of an experimental rabbit model. Methods: Atherosclerotic plaques were induced by endothelial abrasion of the right carotid artery and abdominal aorta of 7 rabbits fed an atherogenic diet. Five noninjured rabbits fed a chow diet were used as controls. Rabbits were imaged on a PET/MR system after injection of 68Ga-pentixafor (15 MBq/kg). Vascular signal was quantified as tissue-to-background ratio (TBR). Biodistribution and autoradiographic studies were performed 1 h after injection of 125I-pentixafor (7.5 MBq/kg). In addition, blocking studies were performed in 2 atherosclerotic rabbits with preinjection of the CXCR4 inhibitor AMD3100. Tracer uptake was quantified on arterial cryosections using autoradiography and compared with CXCR4 and RAM-11 (macrophage) expression on adjacent histologic sections. Results: One hour after injection of 68Ga-pentixafor, strong signals were detected in vivo with PET/MR imaging in atherosclerotic plaques of the abdominal aorta and right carotid artery as compared with normal control arteries (mean TBR = 1.95 ± 0.51 vs. 1.22 ± 0.25 and mean TBR = 1.24 ± 0.38 vs. 0.96 ± 0.37, respectively; P < 0.05 for both). Blocking studies with preinjection of a CXCR4 inhibitor reduced 125I-pentixafor uptake in atherosclerotic plaques by approximately 40%. 125I-pentixafor uptake in the vessel wall on autoradiographies was located in macrophage-rich regions of atherosclerotic plaques and correlated with the intensity of CXCR4 expression on corresponding cryosections (r2 = 0.61; P < 0.05). Conclusion:68Ga-pentixafor allows for the noninvasive detection of CXCR4 expression in the vessel wall with PET and emerges as a potential alternative to 18F-FDG for the assessment of macrophage infiltration in atherosclerotic plaques.
Keywords: CXCR4; PET; atherosclerosis; inflammation; macrophages; radiotracer.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.
Similar articles
-
[68Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery.Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1616-1625. doi: 10.1007/s00259-019-04322-7. Epub 2019 Apr 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 31004184 Free PMC article.
-
Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: Correlation with 18F-FDG PET/CT.J Nucl Med. 2020 May;61(5):751-756. doi: 10.2967/jnumed.119.234484. Epub 2019 Oct 25. J Nucl Med. 2020. PMID: 31653710
-
[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques.Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):558-566. doi: 10.1007/s00259-017-3831-0. Epub 2017 Sep 21. Eur J Nucl Med Mol Imaging. 2018. PMID: 28932900 Free PMC article.
-
Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor.Semin Nucl Med. 2024 Jan;54(1):163-170. doi: 10.1053/j.semnuclmed.2023.09.002. Epub 2023 Nov 3. Semin Nucl Med. 2024. PMID: 37923671 Free PMC article. Review.
-
Imaging findings and clinical relevance of 68Ga-Pentixafor PET in atherosclerosis: a systematic review.BMC Med Imaging. 2023 Oct 26;23(1):166. doi: 10.1186/s12880-023-01134-y. BMC Med Imaging. 2023. PMID: 37884885 Free PMC article.
Cited by
-
CXCR4-directed theranostics in oncology and inflammation.Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Ann Nucl Med. 2018. PMID: 30105558 Free PMC article. Review.
-
Radionuclide imaging of inflammation in atherosclerotic vascular disease among people living with HIV infection: current practice and future perspective.Eur J Hybrid Imaging. 2019 Apr 11;3(1):5. doi: 10.1186/s41824-019-0053-7. Eur J Hybrid Imaging. 2019. PMID: 34191183 Free PMC article. Review.
-
Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation.J Imaging. 2022 Sep 27;8(10):261. doi: 10.3390/jimaging8100261. J Imaging. 2022. PMID: 36286355 Free PMC article. Review.
-
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.Theranostics. 2020 Jul 9;10(18):8264-8280. doi: 10.7150/thno.45537. eCollection 2020. Theranostics. 2020. PMID: 32724470 Free PMC article.
-
Lipoprotein (a), Inflammation, and Atherosclerosis.J Clin Med. 2023 Mar 27;12(7):2529. doi: 10.3390/jcm12072529. J Clin Med. 2023. PMID: 37048611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical